Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CSL Ltd. Director's Dealing 2022

Sep 1, 2022

17854_rns_2022-09-01_8c7747d7-9c6a-4388-8a51-d1c88968789c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [205 x 32] intentionally omitted <==

==> picture [59 x 30] intentionally omitted <==

==> picture [262 x 27] intentionally omitted <==

For immediate release

2 September 2022

Change of Director’s Interest Notice

CSL Limited (ASX;CSL: USOTC:CSLLY)

The attached Appendix 3Y relates to changes in the relevant interest in the Company’s securities held by the Chair of CSL Limited, Dr Brian McNamee AO.

Following approval through CSL’s governance processes, Dr McNamee has sold 10% of his holding, representing 16,370 shares. The proceeds of the sale will be used to meet personal and philanthropic obligations.

Following this transaction, Dr McNamee continues to hold a significant interest in the Company’s securities, comprising 146,276 ordinary shares and he continues to be one of CSL’s largest private shareholders.

Further details are provided in the Appendix 3Y.

Authorised by Fiona Mead Company Secretary

FURTHER INFORMATION

For further information, please contact: Investors: Media: Steve McKeon Jimmy Baker Associate Director, Investor Relations Communications, Asia Pacific CSL Limited CSL Limited Mobile +61 402 231 696 Mobile +61 450 909 211 Email: [email protected] Email: [email protected]

==> picture [99 x 7] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CSL Limited ABN 99 051 588 348

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Brian McNamee AO
Date of last notice 31 August 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Custodian, Trustee and/or Nominee:
Mutual
Trust
as
custodian for
Brian
McNamee
Mutual Trust as custodian for Brian &
Virginia McNamee Foundation
Solium Nominees (Australia) Pty Ltd as
custodian for Brian McNamee
Date of change 31 August 2022
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Indirect:
131,069 Ordinary Shares held by Mutual
Trust as custodian for Brian McNamee
25,000 Ordinary Shares held by HSBC Bank
Australia Ltd as custodian for Brian
McNamee
3,760 Ordinary Shares held by Mutual Trust
as custodian for Brian & Virginia McNamee
Foundation
2,776 Ordinary Shares held by Solium
Nominees (Australia) Pty Ltd as custodian
for Alalia Pty Ltd
41
Ordinary
Shares
held
by
Solium
Nominees (Australia) Pty Ltd as custodian
for Brian McNamee
608 Rights held under the Plan by Solium
Nominees (Australia) Pty Ltd as custodian
for Alalia Pty Ltd
Class Ordinary Shares
Number acquired Nil
Number disposed 16,370 Ordinary Shares
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
16,329 Ordinary Shares at an average price
of $293.8950 per share and the remaining 41
Ordinary Shares at an average price of
$294.26.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Indirect:
115,000 Ordinary Shares held by Mutual
Trust as custodian for Brian McNamee
25,000 Ordinary Shares held by HSBC Bank
Australia Ltd as custodian for Brian
McNamee
3,500 Ordinary Shares held by Mutual Trust
as custodian for Brian & Virginia McNamee
Foundation
2,776 Ordinary Shares held by Solium
Nominees (Australia) Pty Ltd as custodian
for Alalia Pty Ltd
0 Ordinary Shares held by Solium Nominees
(Australia) Pty Ltd as custodian for Brian
McNamee
608 Rights held under the Plan by Solium
Nominees (Australia) Pty Ltd as custodian
for Alalia Pty Ltd
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
On Market Trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed
above traded during a+closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
If prior written clearance was provided, on what date was this
provided?

Fiona Mead Company Secretary

2 September 2022

  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011